Smarter Utility

 

TMCNet: "Stocks that Standout" picks for today are: AKNS, BSDM, CMTL, DIIG, SMMX

[April 15, 2009]

"Stocks that Standout" picks for today are: AKNS, BSDM, CMTL, DIIG, SMMX

(M2 PressWIRE Via Acquire Media NewsEdge) StandoutStocks.com "Stocks that Standout" picks for today are: Akeena Solar, Inc. (NASDAQ: AKNS), BSD Medical Corp. (NASDAQ: BSDM), Comtech Telecommunications Corp. (NASDAQ: CMTL), Diagnostic Imaging International Corp. (OTCBB: DIIG), Symyx Technologies, Inc. (NASDAQ: SMMX)...and Proudly Introducing Proprietary Push Technology (PPT).


The Newest and Revolutionary Technology for Increasing Investor Visability.

REAL Awareness for REAL Companies.

Click below for a full demonstration.

http://newmediaadvisors.info/newmedia.swf Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at www.Standoutstocks.com Apr 15, 2009 -- Akeena Solar, Inc. (NASDAQ: AKNS), a leading designer and installer of solar power systems, will announce its first quarter 2009 financial results on Wednesday, April 29, 2009. The company will host a conference call on the same day at 11:00 A.M. Pacific (2:00 P.M. Eastern).

To access the call in the U.S., please dial 877-225-1676 and for international callers dial 706-643-9669 approximately 10 minutes prior to the start of the conference call. The conference call will also be broadcast live over the Internet and available for replay for 90 days at www.akeena.com.

In addition, a replay of the call will be available via telephone for one week, beginning two hours after the call. To listen to the telephone replay in the U.S., please dial 800- 642-1687 and for international callers, dial 706-645-9291. The pass code is 94461682.

About Akeena Solar, Inc.

Founded in 2001, Akeena Solar's philosophy is simple: We believe producing clean electricity directly from the sun is the right thing to do for our environment and economy. Akeena Solar has grown to become one of the largest national installers of residential and commercial solar power systems in the United States. The company's new integrated solar panel system, Andalay, is the only solar panel system with integrated racking, wiring and grounding. Andalay panels offer unprecedented reliability, performance and aesthetics.

Apr 15, 2009 -- BSD Medical Corp. (NASDAQ: BSDM) today reported on clinical data presented by Rudiger Wessalowski, M.D, Associate Professor at the Clinic of Pediatric Hematology and Oncology, Heinrich-Heine University, Dusseldorf, Germany, on the use of hyperthermia combined with chemotherapy and tumor resection to treat malignant germ cell tumors in children and adolescents. Dr. Wessalowski presented an update of his clinical study at the annual Society for Thermal Medicine (STM) meeting that was held in Tucson, Arizona on April 4 to April 7, 2009.

Dr. Wessalowski reported on the use of the BSD-2000 to treat 101 pediatric patients who ranged from age 7 months to 17 years old with a median age of five years. Of these 101 patients, 46 patients had malignant germ cell tumors. Of the 46 patients with germ cell tumors, there were 23 patients who had a complete response (disappearance of all local disease) and 8 patients with a partial response (greater than 50% reduction). The median follow-up was 5 years. The best responders were patients who received the combined treatment as first time therapy.

Dr. Wessalowski noted that standard therapies are often not effective for certain children's cancers, and relapse therapy is often not effective or available. The study was designed to not only improve survival but also avoid mutilating surgery. Dr. Wessalowski reported that the results of the current study found that combined hyperthermia and platinum-based chemotherapy can be used in children and adolescents. This regimen was found to result in objective tumor response (complete plus partial response) in approximately 67% of study patients who had germ cell tumors. According to Dr. Wessalowski, preoperative platinum-based chemotherapy combined with regional hyperthermia facilitates complete tumor resection in some patients.

Dr. Wessalowski also presented magnetic resonance images showing the temperature changes in children using the BSD-2000/3D/MR to deliver the hyperthermia and simultaneously measure the temperature changes. The Heinrich-Heine University, Dusseldorf, Germany had recently added a new BSD-2000/3D/MR system to further enhance the treatment capacity of its hyperthermia therapy program. The new system integrates a BSD-2000/3D Deep Regional Hyperthermia System with a Siemens 1.5 Magnetic Resonance Imaging (MRI) system. To accommodate the treatment of children, the system uses a set of reduced-size, special pediatric applicators.

About Heinrich-Heine University, Dusseldorf, Germany The University Pediatric Oncology Clinic at Dusseldorf has taken the lead on several national and international studies designed to optimize pediatric oncology therapy. For more than 10 years the Dusseldorf Pediatric Oncology Department has pioneered the application of hyperthermia therapy for treating children's cancers using a BSD-2000 for the treatment of soft tissue sarcomas and germ cell tumors.

About BSD Medical Corporation BSD Medical is a leading developer of systems used to provide cancer therapies requiring precision-focused heat through RF/microwave technologies. The company's systems have been designed to kill cancer through heat alone, and as companion therapies to improve the combined results when used along with radiation treatments. The BSD-2000 is limited to investigational use in the United States.

Apr 15, 2009 -- Comtech Telecommunications Corp. (NASDAQ: CMTL) announced today that its Tempe, Arizona-based subsidiary, Comtech EF Data Corp., won a $2.1 million order for satellite communications equipment from the United States military. The equipment will be used to upgrade existing battlefield systems to operate using the Wideband Global Satcom (WGS) system.

The order included the DMD2050 Satellite Modem, a MIL-STD-188-165A compliant universal satellite modem that supports a wide variety of data rates up to 52 Mbps. Designed for military and government use, it is ideally suited for flyaway, at-the-halt and integrated satellite terminal applications.

Fred Kornberg, President and Chief Executive Officer of Comtech Telecommunications Corp. commented, "This order is another example of how Comtech's innovative equipment serves an integral role in enhancing communications for our country's warfighters." Comtech EF Data Corp. manufactures a broad spectrum of satellite communications products, including Satellite Modems, Bandwidth & Capacity Management, TCP/IP Performance Enhancement Proxies, Encapsulators, Receivers, Converters, Amplifiers, Transceivers and Terminals. All products meet or exceed the standards published by worldwide and regional satellite networks.

Apr 13, 2009 -- Diagnostic Imaging International Corp. (OTCBB: DIIG) announced today that its wholly owned subsidiary, Canadian Teleradiology Services ("CTS"), has signed a new contract with 10 Hospitals.

CTS recently received the contract rights to service the Teleradiology needs of 10 hospitals in Ontario. Night time and weekend service has already begun and the feedback from the hospitals has been very positive.

With this addition, CTS expects to double its monthly study reads and has hit a critical milestone in terms of volume in the Company's history that will move the Company towards profitability.

"CTS is very excited to be able to assist the healthcare needs of this region", said Richard Jagodnik, CEO. "As CTS grows we look forward to filling the radiology shortfall many rural hospitals experience." Apr 15, 2009 -- Symyx Technologies, Inc. (NASDAQ: SMMX) today announced it has been awarded a grant by the United States Department of Energy (DOE) to conduct research and development of advanced heat transfer fluids for solar thermal power generation. Symyx's research will focus on developing new, breakthrough materials for lowering the cost of electricity and providing cleaner energy sources.

"Being recognized with this award validates our ability to utilize microscale, parallel experimentation and scientific informatics to increase the potential for breakthrough discoveries in this critical area of energy research," said Richard Boehner, president, High Productivity Research (HPR) at Symyx. "We're excited to extend our high-throughput experimentation capabilities beyond our environmentally-friendly fuels development with leading automotive and energy companies and into solar thermal energy for green technology power generation." Today, large solar thermal power facilities are comprised of many miles of fluid-filled pipes arranged in large grids with reflective mirrors used to capture radiation from the sun. Solar radiation heats the fluid which is used to produce steam necessary to power large electricity generation turbines. Currently, organic, oil-based fluid in the pipes has a maximum temperature threshold of 400 degrees Celsius, allowing for the production of electricity at approximately 15 cents per kilowatt hour. By funding Symyx's work, the DOE hopes to foster the development of an advanced heat transfer fluid that can operate within a temperature range from 80 degrees Celsius up to 500 degrees Celsius. The new heat transfer fluid, when used with other advanced technologies, could significantly decrease solar electricity cost to as low as 5 to 7 cents per kilowatt hour. Lower costs would make solar thermal electricity competitive with gas and coal and would offer a clean, renewable source of energy.

Symyx is utilizing proprietary, high productivity research (HPR) tools such as Symyx Powdernium, and its own scientific informatics software including Symyx Automation Studio to screen deep eutectic salt formations, critical to the discovery of materials with low melting points that are able to withstand higher maximum temperatures. Following the screening phase, Symyx will conduct field testing of new material candidates, with the goal of developing a new advanced heat transfer fluid candidate for commercialization in the solar thermal power industry.

While the DOE selected more than a dozen organizations and academic institutions to develop improved methods for thermal energy storage, Symyx was the only company chosen to research advanced heat transfer fluids. Symyx was selected based on the technical merit of its proposed material innovation, as well as its demonstrated experience in high-throughput experimentation in related programs with energy and chemical companies. The competitive grant process that selected Symyx also considered the caliber of the proposed research team members, relevant research infrastructure and overall capabilities.

About Symyx Symyx Technologies, Inc. enables companies in life sciences, chemicals and energy, and consumer and industrial products to transform scientific R&D and achieve extraordinary breakthroughs in productivity and return on investment. Symyx scientific information management enables scientists to design, execute, analyze, and report experimental results faster, easier, and less expensively. Symyx microscale, parallel experimentation enables a single scientist to rapidly explore a broad experimental space and develop comprehensive data sets in days -- not weeks or months. Symyx contract research delivers these advantages on a project basis and enables companies to increase R&D productivity, agility, and flexibility.

About Standoutstocks.com Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.

Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.aspx ((Comments on this story may be sent to info@m2.com)) (c) 2009 M2 COMMUNICATIONS LTD

[ Back To Homepage ]